Skip to main content
Log in

Costs seldom considered in clinical guidance documents

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Center for Innovative Care, Chesterfield (MO, USA)

References

  1. Schwartz JA, et al. Cost Consideration in the Clinical Guidance Documents of Physician Specialty Societies in the United States. JAMA Internal Medicine : 1-7, 6 May 2013. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2013.817

    Google Scholar 

  2. Drozda JP. Physician Specialty Society Clinical Guidelines and Bending the Cost Curve: Comment on "Cost Consideration in the Clinical Guidance Documents of Physician Specialty Societies in the United States". JAMA Internal Medicine : 1-2, 6 May 2013. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2013.820

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costs seldom considered in clinical guidance documents. PharmacoEcon Outcomes News 679, 4 (2013). https://doi.org/10.1007/s40274-013-0427-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0427-1

Navigation